E-Beam | X-Ray Sterilization
The Benefits and Advantages of Using E-Beam for Sterilization | Newsletter | Issue 01 | 2020
Understanding Terminal Sterilization | Newsletter | Issue 02 | 2020
E-Beam Sterilization Technology: Key Facts | Newsletter | Issue 03 | 2020
Terminal Sterilization of Pharmaceuticals - Why E-Beam Is Superior | Newsletter | Issue 04 | 2021
Terminal Sterilization: How Demand Is Leading Innovation | Newsletter | Issue 05 | 2021
Aseptic Fill vs. Terminal Sterilization | Newsletter | Issue 06 | 2021
Understanding Sterile Compounding & Beyond-Use Dating (BUD) | Newsletter | Issue 07 | 2021
Sterility Assurance - Foundational Principles and Current Realities | Newsletter | Issue 08 | 2022
Sterilization By Electron Beam Processing | Newsletter | Issue 09 | 2022
Irradiation in Drug Compounding: A Deep Dive into Sterilization Standards and Bioburden Management | Newsletter | Issue 13 | 2023
Packaging Solutions
Time Sensitive Cold Chain Solutions | Newsletter | Issue 01 | 2020
Innovative Packaging And Materials - Why It Matters | Newsletter | Issue 02 | 2020
Pharmaceutical & Biologics Packaging Testing | Newsletter | Issue 03 | 2020
Industry Leader Packaging Supplier | Newsletter | Issue 04 | 2021
Packaging Closures for Pharmaceutical Products | Newsletter | Issue 05 | 2021
Form Meets Function In Pharmaceutical Packaging | Newsletter | Issue 06 | 2021
Understanding the Roles In Pharmaceutical Packaging | Newsletter | Issue 07 | 2021
Trends Shaping The Future Of Pharmaceutical Packaging | Newsletter | Issue 08 | 2022
Pharmaceutical Packaging from Drug Conception to Injection | Newsletter | Issue 10 | 2022
The Best Primary Packaging Solutions for Injectables | Newsletter | Issue 11 | 2023
Compliance
Changes In the New USP 797 Regulations | Newsletter | Issue 01 | 2020
ISO Regulations and MediZap Protocols | Newsletter | Issue 02 | 2020
483 Observations and Warnings - What’s The Difference? | Newsletter | Issue 03 | 2020
Best Practices for Temperature Validation & Compliance | Newsletter | Issue 04 | 2021
Quality by Design - Regulatory Compliance in Pharmaceuticals | Newsletter | Issue 05 | 2021
cGMP Controlled Raw Materials Best Practices | Newsletter | Issue 06 | 2021
Common Pharmaceutical Compliance Issues & How to Avoid Them | Newsletter | Issue 07 | 2021
Bioburden & Sterilization Validation Of Pharmaceuticals | Newsletter | Issue 08 | 2022
Interim Pandemic Compounding Compliance Is About To Expire | Newsletter | Issue 09 | 2022
503A and 503B Compounding Regulations by FDA Regulatory Body | Newsletter | Issue 10 | 2022
Testing Container Closure Integrity in Compounded Parenteral Drug Products | Newsletter | Issue 12 | 2023
Exclusive Partnerships
ISO Regulations and MediZap Protocols | Newsletter | Issue 02 | 2020
SiO2 Scales Manufacturing Of COVID-19 Vaccine Vials | Newsletter | Issue 03 | 2021
MediZap Announces Exclusive Partnership with ALG | Element | Newsletter | Issue 04 | 2021
SteriTek Dallas Grand Opening and MediZap Exclusive Partnership | Newsletter | Issue 06 | 2021
PR- MediZap Attends APC - Compounders on Capitol Hill 2021 | Newsletter | Issue 07 | 2021
PR- MediZap Attends A4M World Congress & Exhibiting At Venetian Expo | Newsletter | Issue 07 | 2021
Guidance and Review of New USP 797 Changes | Newsletter | Issue 08 | 2022
New SteriTek Dallas Facility Brings X-Ray Technology | Newsletter | Issue 09 | 2022
The Benefits of X-Ray Terminal Sterilization for Sterile Compounded IV Bag | Newsletter | Issue 10 | 2022